Evaluation of Neoplasia With Artificial Intelligence in Gastrointestinal Endoscopy
NEW-AGE
Collection of Endoscopic Images and Videos for Validation of Artificial Intelligence Algorithms for Computer Aided Detection and Characterisation of Early Gastrointestinal Neoplasia
1 other identifier
observational
1,650
1 country
1
Brief Summary
This study aims to validate and evaluate AI algorithms for detection and characterization of early GI neoplasia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2021
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 9, 2021
CompletedStudy Start
First participant enrolled
June 16, 2021
CompletedFirst Posted
Study publicly available on registry
June 24, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 3, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
June 3, 2026
December 23, 2025
December 1, 2025
5 years
June 9, 2021
December 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
neoplasia detection rate
neoplasia detection rate of the AI algorithms in different locations of the GI tract.
during the procedure, up to 24 weeks, at 1 year, through study completion
Secondary Outcomes (2)
Accuracy of AI diagnosis
during the procedure, up to 24 weeks, at 1 year, through study completion
Endoscopist neoplasia detection rate
during the procedure, up to 24 weeks, at 1 year, through study completion
Interventions
collection of endoscopic images and videos
Eligibility Criteria
In phase (1), all previously collected, anonymized and stored endoscopic images and videos of early GI neoplasia in the departmental endoscopy teaching and training library. In phase (2), all eligible patients coming for upper and/or lower GI endoscopy for clinical reasons in participating centres will be approached for enrolment into this study.
You may qualify if:
- The participant must meet ALL of the following criteria to be considered eligible for the study:
- Male or Female, aged 18 years or above.
- Requiring gastroscopy and/or colonoscopy to investigate gastrointestinal symptoms, or as part of screening or ongoing surveillance of GI neoplasia.
- Participant is willing and able to give informed consent for participation in the study.
You may not qualify if:
- The participant may not enter the study if ANY of the following apply:
- Patients with endoscopically active severe oesophagitis
- Poor bowel preparation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Portsmouth Hospitals NHS University Trust
Portsmouth, Hampshire, PO63LY, United Kingdom
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pradeep Bhandari, Prof
Portsmouth Hospitals University NHS Trust
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 9, 2021
First Posted
June 24, 2021
Study Start
June 16, 2021
Primary Completion (Estimated)
June 3, 2026
Study Completion (Estimated)
June 3, 2026
Last Updated
December 23, 2025
Record last verified: 2025-12
Data Sharing
- IPD Sharing
- Will not share